FDA grants expedited status for bluebird bio’s gene therapy – WRAL Tech Wire
WRAL Tech Wire |
FDA grants expedited status for bluebird bio's gene therapy
WRAL Tech Wire DURHAM – bluebird bio, a gene therapy company with operations in Durham, has received Breakthrough Therapy designation from the U.S. Food and Drug Administration for Lenti-D, its potential treatment for a rare and life-threatening neurological disorder … |
